Comment
doi: 10.1136/ebm.15.1.7.
High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types
Affiliations
- PMID: 20176866
- DOI: 10.1136/ebm.15.1.7
Item in Clipboard
Comment
High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types
Evid Based Med.
2010 Feb.
No abstract available
Comment on
-
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6. Lancet. 2009. PMID: 19586656 Clinical Trial.
Similar articles
-
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Gynecol Oncol. 2008. PMID: 18653221 Review.
-
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girls.J Adolesc Health. 2010 May;46(5):414-21. doi: 10.1016/j.jadohealth.2010.02.006. J Adolesc Health. 2010. PMID: 20413076 Clinical Trial.
-
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.Expert Rev Vaccines. 2008 Dec;7(10):1465-73. doi: 10.1586/14760584.7.10.1465. Expert Rev Vaccines. 2008. PMID: 19053203 Review.
-
Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Adv Ther. 2009. PMID: 20024678 Review.
-
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.Gynecol Oncol. 2009 Dec;115(3 Suppl):S1-6. doi: 10.1016/j.ygyno.2009.01.011. Epub 2009 Feb 12. Gynecol Oncol. 2009. PMID: 19217149
Cited by
-
Does the HPV vaccination programme have implications for cervical screening programmes in the UK?Vaccine. 2014 Apr 1;32(16):1828-33. doi: 10.1016/j.vaccine.2014.01.087. Epub 2014 Feb 13. Vaccine. 2014. PMID: 24530938 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
